Assignee

Celgene Quanticel Research, Inc.

Patents = 105

Forward Citations = 174

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

31 inventors (with patents filed for the assignee):

Celgene Quanticel Research, Inc. is a biotechnology company focused on research and development of innovative therapies for cancer and other diseases. As a subsidiary of Celgene Corporation, Quanticel leverages advanced genomic technologies and bioinformatics to discover and validate targets that may lead to new treatment approaches. The company's mission is to develop precision medicine solutions to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com